Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Anesthesiology|January 19, 2024
Reversal of Propofol-induced Depression of the Hypoxic Ventilatory Response by BK-channel Blocker ENA-001: A Randomized Controlled TrialSimone C Jansen, Maarten van Lemmen, Erik Olofsen, et al.
Anesthesiology|July 22, 2022
Respiratory Effects of the Atypical Tricyclic Antidepressant Tianeptine in Human Models of Opioid-induced Respiratory DepressionHyke Algera, Rutger van der Schrier, David Cavalla, et al.
British Journal of Anaesthesia|February 1, 2023
Inhaled Δ<sup>9</sup>-tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression: randomised controlled trial in healthy volunteersCornelis Jan van Dam, Rutger van der Schrier, Monique van Velzen, et al.
Plos One|January 27, 2022
Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patientsLaurence M Moss, Marijke Hyke Algera, Robert Dobbins, et al.
Anesthesiology|December 20, 2022
Respiratory Effects of Biased Ligand Oliceridine in Older Volunteers: A Pharmacokinetic-Pharmacodynamic Comparison with MorphinePieter Simons, Rutger van der Schrier, Maarten van Lemmen, et al.
Trials|October 27, 2021
The impact of deep versus standard neuromuscular block on intraoperative safety during laparoscopic surgery: an international multicenter randomized controlled double-blind strategy trial - EURO-RELAX TRIALMaarten Honing, Gabby Reijnders-Boerboom, Salome Dell-Kuster, et al.
British Journal of Anaesthesia|October 23, 2020
Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgeryG H Maarten Honing, Christian H Martini, Erik Olofsen, et al.
Scientific Reports|September 18, 2020
Causes and consequences of the opioid epidemic in the Netherlands: a population-based cohort studyAjda Bedene, Eveline L A van Dorp, Tariq Faquih, et al.
Anesthesiology|January 13, 2025
TAK-925 (Danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-induced Respiratory Depression and Sedation without Affecting Analgesia in Healthy MenMaarten van Lemmen, Albert Dahan, Yaming Hang, et al.
Investigative Ophthalmology & Visual Science|May 6, 2017
Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic PainDaniel A Culver, Albert Dahan, Daiva Bajorunas, et al.
Pageof 11